Olga A. Novikova

Olga A. Novikova

Auto-generated profile, based on publicly available information

Olga A. Novikova

Meshalkin National Medical Research Center

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2018 in Annals of Vascular Surgery
Verified
Journal Article
Closed access
ONOlga A. Novikova
Olga A. Novikova
PLPavel P. Laktionov
Pavel P. Laktionov
AKAndrey Karpenko
Andrey Karpenko

13 November 2020 in Cardiovascular Therapy and Prevention
Verified
Journal Article
Open access
PDF file
PIP. V. Ignatenko
P. V. Ignatenko
AGAlexander Gostev
Alexander Gostev
ONO. A. Novikova
O. A. Novikova
SSSh. B. Saaya
Sh. B. Saaya
ARA. A. Rabtsun
A. A. Rabtsun
ВСВ. Б Стародубцев
В. Б Стародубцев
Динамика гемодинамических параметров при различных видах каротидной эндартерэктомии в ближайшем и отдаленном послеоперационном периоде у пациентов со стенозирующим каротидным атеросклерозом

25 November 2022 in Siberian Journal of Clinical and Experimental Medicine
Verified
Journal Article
Open access
PDF file
TITatyana Ilyicheva
Tatyana Ilyicheva
SNSergey Victorovich Netesov
Sergey Victorovich Netesov
OAO. A. Abubakirova
O. A. Abubakirova
Vadim N. GureyevVadim N. Gureyev
Vadim N. Gureyev
Acute respiratory viral infections are the most common human diseases. Symptoms of the infection vary from a slight cold to critical condition requiring artificial lung ventilation and support of cardiovascular system. Main risk factors of severe disease include high viral load, co-infection with other pathogens, age from 0 to 2 years and older than 65 years, and immunodeficiency. Cardiac manifestations of the infection are usually caused by indirect effects due to inflammatory reaction resulting in systemic increase in proinflammatory cytokines, so called cytokine storm. However, there have been reports on the identification of respiratory viruses isolated directly from the myocardial tissue, or testing of viral RNA in the myocardium using real-time polymerase chain reaction. This review discusses the direct and indirect effects of respiratory viral infections on causing cardiovascular complications. The authors discuss the similarities and differences of the immunopathogenic mechanisms associated with COVID-19, influenza infection, as well as diseases caused by enteroviruses, respiratory syncytial viruses, metapneumoviruses, and parainfluenza viruses.

20 August 2018 in Cardiovascular Therapy and Prevention
Verified
Journal Article
Open access
PDF file
ACA. V. Cheban
A. V. Cheban
AKA. A. Karpenko
A. A. Karpenko
IPI. V. Popova
I. V. Popova
SSSh. B. Saaya
Sh. B. Saaya
AGAlexander Gostev
Alexander Gostev
PLPavel P. Laktionov
Pavel P. Laktionov
Endovascular interventions have proved efficacy in the treatment of the shin arteries lesion management. Lots of published works witness on the significance and future perspective of the field. The article is focused on the analysis of studies for previous 5 years, on various treatment approaches, balloons and cytostatics coated stents usage. The ways for interventions relsults improvement are sketched on tibial arteries with drug eluting stents.

25 November 2022 in Siberian Journal of Clinical and Experimental Medicine
Verified
Journal Article
Open access
PDF file
TITatyana Ilyicheva
Tatyana Ilyicheva
SNSergey Victorovich Netesov
Sergey Victorovich Netesov
OAO. A. Abubakirova
O. A. Abubakirova
Vadim N. GureyevVadim N. Gureyev
Vadim N. Gureyev
Acute respiratory viral infections are the most common human diseases. Symptoms of the infection vary from a slight cold to critical condition requiring artificial lung ventilation and support of cardiovascular system. Main risk factors of severe disease include high viral load, co-infection with other pathogens, age from 0 to 2 years and older than 65 years, and immunodeficiency. Cardiac manifestations of the infection are usually caused by indirect effects due to inflammatory reaction resulting in systemic increase in proinflammatory cytokines, so called cytokine storm. However, there have been reports on the identification of respiratory viruses isolated directly from the myocardial tissue, or testing of viral RNA in the myocardium using real-time polymerase chain reaction. This review discusses the direct and indirect effects of respiratory viral infections on causing cardiovascular complications. The authors discuss the similarities and differences of the immunopathogenic mechanisms associated with COVID-19, influenza infection, as well as diseases caused by enteroviruses, respiratory syncytial viruses, metapneumoviruses, and parainfluenza viruses.